Cellosaurus A-375 KRAS p.G13D (CVCL_UD29)
Cell line name | A-375 KRAS p.G13D | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms | A-375 KRASG13D; KRAS mutant-A375 Isogenic Cell Line | ||||||||||||||||||
Accession | CVCL_UD29 | ||||||||||||||||||
Resource Identification Initiative | To cite this cell line use: A-375 KRAS p.G13D (RRID:CVCL_UD29) | ||||||||||||||||||
Comments | Population: Caucasian. Characteristics: Exhibits significant resistance to the BRAF inhibitors Dabrafineb and Vemurafenib when compared to its parental cell line. Can be a useful model to study the RAS-RAF-MEK-ERK-MAP kinase signaling pathway and to screen potential BRAF inhibitors and anti-cancer compounds for drug discovery and development (ATCC=CRL-1619IG-1). Doubling time: ~21 hours (ATCC=CRL-1619IG-1). Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511. | ||||||||||||||||||
Sequence variations |
| ||||||||||||||||||
Disease | Amelanotic melanoma (NCIt: C3802) | ||||||||||||||||||
Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) | ||||||||||||||||||
Hierarchy | Parent: CVCL_0132 (A-375) Children:
| ||||||||||||||||||
Sex of cell | Female | ||||||||||||||||||
Age at sampling | 54Y | ||||||||||||||||||
Category | Cancer cell line | ||||||||||||||||||
STR profile | Source(s): ATCC=CRL-1619IG-1 Markers:
Run an STR similarity search on this cell line | ||||||||||||||||||
Web pages | https://www.atcc.org/en/support/technical-support/faqs/isogenic-cell-line-with-ras-mutation | ||||||||||||||||||
Cross-references | |||||||||||||||||||
Cell line collections (Providers) | ATCC; CRL-1619IG-1 | ||||||||||||||||||
Cell line databases/resources | cancercelllines; CVCL_UD29 | ||||||||||||||||||
Encyclopedic resources | Wikidata; Q93311029 | ||||||||||||||||||
Entry history | |||||||||||||||||||
Entry creation | 13-Nov-2018 | ||||||||||||||||||
Last entry update | 10-Sep-2024 | ||||||||||||||||||
Version number | 13 |